Enfermedades
colágeno-vasculares
1. Moreno RJ. Respuesta
inmune y mecanismos de autoinmunidad. 1ª ed; México DF: Noriega
Editores 1996, pp 120-132.
2. Roitt I, Brostoff J, Male D. Autoinmunity and autoinmune disease. Inmunology
, 2a ed; New York: Gaver Medical Publishing 1989. pp 231-234.
3. Saúl A. Lecciones de dermatología. 12 ed, Méndez
Cervantes editores, México 1993:457-477.
4. Blancas FG. Anticuerpos antinucleares y lesiones cutáneas en
lupus eritematoso sistémico. Tesis de posgrado UNAM. Hospital General
de México. México DF, 1989.
5. Hopkinson N. Epidemiology of systemic lupus erythematosus. Ann Rheum
Dis 1992; 51(12):1292-1294.
6. Tan EM. Inmunopatology and pathogenesis of cutaneus involvement in
systemic lupus erythematosus. J Invest Dermatol 1976;67:360-365.
7. Boumpas DT, et al. Systemic Lu-
pus Erythematosus: Emerging Concepts. Part 1: Renal, neuropsychiatric,
cardiovascular, pulmonary and hematologic disease. Ann Intern Med 1995;122:940-950.
8. León G. Manifestaciones cutáneas de enfermedades del
tejido conjuntivo. En Abréu RL Tratado de Medicina Interna. Méndez
Cervantes Editores, México; 1989:15.62-15.67.
9. Ballou SP. Systemic lupus erythematosus. Controversies in management,
Posgrad Med 1987;81:157-164.
10. Lampe N, León G, Blancas F. Lupus Pérnio. Reporte de
caso clínico. Dermatología Rev Mex 1996; 39(4): 273-274.
11. Alarcón-Segovia D, et al. Antiphospholipid antibodies and the
antiphospholipid síndrome in systemic lupus erythematosus: A prospective
análisis of 500 consecutive patients. Medicine 1989;60:353-374.
12. Petri M. Patogenia y tratamiento del síndrome de anticuerpos
antifosfolípidos. En Snyderman R. Clin Med Norteam. México,
Mc Graw-Hill Interamericana 1997;1:145-170.
13. Mercadillo P. Dermatomiositis. Estudio de 14 casos y revisión
de la literatura. Tesis de posgrado UNAM, Hospital General de México.
México DF, 1980.
14. Kovacs SO, Kovacs SC. Dermatomyositis. J Am Acad Dermatol 1998; 39(6):899-922.
15. Reynés-Manzur JN, et al. Aspectos clínicos y terapéuticos
de la dermatomiositis juvenil. Bol Med Hosp Inf Mex 1994;51(4):256-266.
|
16. Lakhanpal S, et
al. Polymyositis-dermatmyositis and Malignant Lesions: Does an Association
Exist? Mayo Clin Proc 1986;61(8):645-653.
17. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis
sine myositis). J Am Acad Dermatol 1991;24(6):959-966.
18. Doyle JA, Connolly SM, Winkelmann RK. Cultaneus and subcutaneous inflammatory
sclerosis syndrome. Arch Dermatol 1982;118 (11):886-889.
19. Tuffanelli DL, Winkelmann RK. Systemic Scleroderma. A clinical study
of 727 cases. Arch Dermatol 1961;84(9):369-371.
20. Masi AT, et al. Preliminary criteria for the classification of systemic
sclerosis (scleroderma). Arthritis Rheum 1980;23(5):581-590.
21. Drake LA, et al. Guidelines of cara for scleroderma and sclerodermoid
disorders. J Am Acad Dermato 1996;35:609-14.
22. Bruns M, Herrman K, Haustein UF. Immunologic parameters in systemic
sclerosis. Int J Dermatol 1994;33:25-32.
23. Arenas R. Dermatología: Atlas, diagnóstico y tratamiento.
2ª ed, Mc Graw Hill 1996:103-123.
24. Buechner SA, Rufli T. Atrophoderma of Pasini and Pierini. Clinical and
Histopathologic findings and antibodies to Borrelia burgdorferi in thirty-four
patients. J Am Acad Dermatol 1994;30:441-446.
25. Gilliam JN, Prystowsky SD. Mixed connective tissue disease syndrome.
Arch Dermatol 1977;113(5):583-587.
26. Alarcón –Segovia D. Mixed connective tissue disease. A disorder
of immune regulation. Arthr Rheum 1983;13(Suppl.1):114.
27. Sharp GC, Anderson PC. Current concepts in the classification of connective
tissue disease. J Am Acad Dermatol 1980;2:269-279.
28. Plata-Bernal C, Talal N. Overlap síndromes: mixed connective
tissue disease and Sjögren syndrome In Lahita RG, Systemic Lupus Erythematosus,
2nd ed. New York. Churchill Livimgstone 1992:437-446.
29. Blancas F, León G, Reyes P. Anticuerpos antinucleares y lesiones
cutáneas en lupus eritematoso sistémico. Intentos de correlación.
Dermatol Rev Mex 1990;34(3):179-188.
30. Sontheimer RD, Jan SD. Antunuclear and Antitoplasmic Antibodie. J Am
Acad Dermatol 1983;9:335-343.
31. Burham TK- Antinuclear antibodies. A simplified classification of the
nuclear inmunofluorescent patterns. Arch Dermatol 1978;114:1343-344.
32. Rose NR, Herman F, Fahey JL. Unmunofluorescent Antinuclear Antibody
test. Manual of Clinical Laboratory Inmunology. Washington DC American Society
for Microbiology. 3a ed 1986:733-754. |
33. Mutasim DF, Adams
BB. A practical guide for serologic evaluation of autoinmune connective
tissue diseases. J Am Acad Dermatol 2000;42:159-174.
PÉNFIGO
1. Díaz LA,
et al. End of the century overview of skin blisters. Arch dermatol 2000;136:106-112.
2. Fitzpatrick’s, et al. Dermatology in General Medicine. New York.
McGraw Hill. 5th edition 1999;(1): 654-666.
3. Korman N, et al. Pemphigus. J Am Acad Dermatol 1988;18(6:1219-1238).
4. Braun Falco O. The pathology of blister formation. Year book Medical
pub. Chicago 1969;6-42.
5. Robinson ND, et al. The new pemphigus variants. J Am Acad Dermatol
1999;40(5):649-671.
6. Meurer M. Millings et al. Oral pemphigus vulgaris. Arch Dermatol 1977;113:1520-1524.
7. Kaplan RP, et al. Esophagitis dissecans superficialis associated with
pemphigus vulgaris. J Am Acad Dermatol 1981;4:682-687.
8. Crosby D, Diaz L. Dermatologic Clinics Bullous Diseases. Philadelphia
P.A. W. B. Sanders. 1993;11:429-481.
9. Premalatha S, et al. Cerebriform tongue. A clinical sign in pemphigus
vegetans. Br J Dermatol 1981;104:
587-591.
10. Díaz LA, et al. Endemic pemphigus foliaceus (fogo salvagem).
Clinical features and inmmunopathology. J Am Acad Dermatol 1989;20:657-59.
11. Roscoe JT, et al. Elevated thymosin alpha 1 levels in Brazilian pemphigus
foliaceus. Br J Dermatol 1986;115:147-150.
12. Stanley JR, et al. Antigenic specificity of fogo salvagem autoantibodies
in similar to North american pemphigus foliaceus and distinct from pemphigus
vulgaris. J Invest Dermatol 1986;87:197-201.
13. Ngo AW, Straka C. Pemphigus erythematosus: a unique association with
systemic lupus erythematosus. Cutis 1986;38:160-163.
14. Horn TA, Anhalt GJ. Histologic features of paraneoplastic pemphigus.
Arch Dermatol 1992;128:1091-1095.
15. Jablonska S, et al. Herpetiform pemphigus, a variable pattern of pemphigus.
Int J Dermatol 1975; 14:353-359.
16. Micoli G. Musumeci ML et al. Epidemiologic Analysis and clinical course
of 84 consecutive cases of pemphigus in eastern Sicily. Int J Dermatol
1998;37:197-200.
|